Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check7 days agoChange DetectedThe page removed related topics Prostate cancer and MedlinePlus Genetics, with no changes to the core study content visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded related topics Prostate cancer and MedlinePlus Genetics and updated the page revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check29 days agoChange DetectedFunding notice and related-topic links were removed from the page; the main study details and trial information remain unchanged.SummaryDifference0.5%
- Check36 days agoChange DetectedAdded related topics links for Prostate cancer and MedlinePlus Genetics, affecting navigation but not study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check50 days agoChange DetectedThe page now includes a Results section with primary and secondary outcomes and updated study dates (start, primary completion, study completion) and enrollment. This provides current information about the trial findings and status.SummaryDifference0.4%
- Check64 days agoChange DetectedDeleted a MedlinePlus Genetics topic related to Prostate cancer, removing it from the page's core topics.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.